Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Etienne Meylan

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Nature Immunology|May 21, 2008
IRAK2 takes its place in TLR signalingEtienne Meylan, Jürg Tschopp
Molecular Cell|June 10, 2006
Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responsesEtienne Meylan, Jürg Tschopp
EMBO Reports|March 4, 2008
NLRX1: friend or foe?Etienne Meylan, Jürg Tschopp
Cell Cycle (Georgetown, Tex.)|August 19, 2017
RIP off STAT3 to counteract tumor progressionJawahar Kopparam, Etienne Meylan
Seminars in Immunology|December 29, 2021
Neutrophil metabolism in the cancer contextAnita Bodac, Etienne Meylan
Trends in Biochemical Sciences|March 9, 2005
The RIP kinases: crucial integrators of cellular stressEtienne Meylan, Jürg Tschopp
Current Opinion in Oncology|January 4, 2013
Targeting receptor activator of nuclear factor-kappa B as a new therapy for bone metastasis in non-small cell lung cancerSolange Peters, Etienne Meylan
Nature|July 11, 2006
Intracellular pattern recognition receptors in the host responseEtienne Meylan, Jürg Tschopp, Michael Karin
Advanced Drug Delivery Reviews|February 19, 2008
Intracellular pattern-recognition receptorsCatherine Dostert, Etienne Meylan, Jürg Tschopp
The FEBS Journal|June 13, 2018
Glucose transporters in cancer - from tumor cells to the tumor microenvironmentPierre-Benoit Ancey, Caroline Contat, Etienne Meylan
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Nature Immunology|May 21, 2008
IRAK2 takes its place in TLR signalingEtienne Meylan, Jürg Tschopp
Molecular Cell|June 10, 2006
Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responsesEtienne Meylan, Jürg Tschopp
EMBO Reports|March 4, 2008
NLRX1: friend or foe?Etienne Meylan, Jürg Tschopp
Cell Cycle (Georgetown, Tex.)|August 19, 2017
RIP off STAT3 to counteract tumor progressionJawahar Kopparam, Etienne Meylan
Seminars in Immunology|December 29, 2021
Neutrophil metabolism in the cancer contextAnita Bodac, Etienne Meylan
Trends in Biochemical Sciences|March 9, 2005
The RIP kinases: crucial integrators of cellular stressEtienne Meylan, Jürg Tschopp
Current Opinion in Oncology|January 4, 2013
Targeting receptor activator of nuclear factor-kappa B as a new therapy for bone metastasis in non-small cell lung cancerSolange Peters, Etienne Meylan
Nature|July 11, 2006
Intracellular pattern recognition receptors in the host responseEtienne Meylan, Jürg Tschopp, Michael Karin
Advanced Drug Delivery Reviews|February 19, 2008
Intracellular pattern-recognition receptorsCatherine Dostert, Etienne Meylan, Jürg Tschopp
The FEBS Journal|June 13, 2018
Glucose transporters in cancer - from tumor cells to the tumor microenvironmentPierre-Benoit Ancey, Caroline Contat, Etienne Meylan
Pageof 5